Assessment of the patient with benign prostatic hyperplasia.
Carlin
B I
BI
Department of Urology, University Hospitals of Cleveland, OH 44106, USA.
Resnick
M L
ML
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000009:adverse effects; D011470:Prostatic Hyperplasia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy; D012307:Risk Factors; D012720:Severity of Illness Index; D014563:Urodynamics
D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors; D018120:Finasteride; D017430:Prostate-Specific Antigen